ENvizion Medical Ltd.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a ENVM.TA research report →
Price Chart
About the company
ENvizion Medical Ltd. is a specialized medical device enterprise. Its primary product is the ENvue system, which streamlines the placement of feeding tubes.
- CEO
- Doron Besser
- IPO
- 2021
- Employees
- 28
- HQ
- Tel Aviv, IL
Get TickerSpark's AI analysis on ENVM.TA
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $139.02M
- P/E
- -10.52
- PEG
- -3.39
- P/S
- 3957.59
- P/B
- -12.71
- EV/EBITDA
- -1122.48
- Div Yield
- 0.00%
- Gross Margin
- -100.61%
- Op Margin
- -538.57%
- Net Margin
- -423.20%
- ROE
- -5.55%
- ROIC
- 293.08%
Latest fiscal year · YoY change
- Revenue
- $11.77K-99.4%
- Gross Profit
- $-11,839+98.2%
- Op Income
- $-63,374
- Net Income
- $-49,798+99.8%
- EPS
- $-0.02+99.8%
- OCF Growth
- +99.8%
- FCF Growth
- +99.9%
- 52W High
- $1994.00
- 52W Low
- $42.00
- 50D MA
- $208.69
- 200D MA
- $601.46
- Beta
- -0.05
- RSI (14)
- 10
- Avg Volume
- 11.32K
No earnings-call transcripts are available for ENVM.TA yet.
- Free Float
- 0.5%
- Shares Outstanding
- 257.44M
- Float Shares
- 1.16M
Our ENVM.TA coverage
Recent articles, reports, and earnings notes.
No research on ENVM.TA yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate ENVM.TA report →